Stay updated with breaking news from Clinical Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New pipeline program builds on academic studies of durable, drug-free remissions in patients with autoimmune disease after CD19-targeted cell therapy NKX019, an allogeneic CAR NK cell therapy targeting CD19+ B
CAMBRIDGE, Mass., Oct. 13, 2023 -- Intellia Therapeutics, Inc. , a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based...
Experts Reviewed Data from QDENGA’s Clinical Program Across 19 Phase 1, 2 and 3 Trials with More Than 28,000 ParticipantsWHO Will Consider the SAGE Recommendation and Provide Final Guidance on the Use of QDENGA in Public Vaccination Programs in the Coming MonthsDengue Poses a Significant and Growing Public Health Bu...
Takeda TSE4502NYSETAK today announced that the World Health Organizations WHO Strategic Advisory Group of Experts SAGE on Immunization shared recommendations for use of QDENGA Dengue Tetravalent Vaccine Live Attenuated TAK003.
KT-333 Phase 1 oncology trial ongoing with an update including initial evaluation of its clinical antitumor activity in patients expected in the fourth quarter of 2023 Fast Track designation can...